Indermitte J, Reber D, Beutler M, Bruppacher R, Hersberger K E
Department of Pharmaceutical Sciences, Institute of Clinical Pharmacy, University of Basel, Basel, Switzerland.
J Clin Pharm Ther. 2007 Apr;32(2):149-59. doi: 10.1111/j.1365-2710.2007.00809.x.
In community pharmacies potential drug interactions between prescription only medicines (POM) and over-the-counter (OTC) drugs purchased for self-medication arise mainly in two situations: (i) if an OTC drug is purchased by a passer-by customer whose prescribed drug therapy is not known; or (ii) if a POM or an OTC drug is requested by a regular customer whose prescribed drug therapy is usually recorded. With this study we aimed to assess the prevalence of potential drug interactions with selected POM and OTC drugs in passer-by and regular customers as well as their awareness of these potential drug interactions.
Data were collected in 14 community pharmacies in the region of Basel, Switzerland by observation of customer contacts and interviews with passer-by customers purchasing selected OTC drugs, and telephone-interviews with regular customers treated with selected POMs identified in community pharmacies' databases. The selected POMs and OTC drugs are drugs which could lead to clinically relevant drug interactions of varying severity but manageable through different interventions such as adjustment of dose and its timing and/or monitoring of the therapy, and avoidance of the combination by choosing an alternative treatment.
Of 1183 passer-by customers observed, 164 (14 x 4%) purchased at least one of the selected OTC drugs. One hundred and two (62 x 2%) of those subjects were interviewed. Forty-three (42 x 2%) mentioned taking prescribed drugs, and three of them were exposed to potential drug interactions of moderate severity. Out of 592 regular customers selected from the community pharmacy database, 434 (73 x 3%) could be interviewed. Sixty-nine (15 x 9%) of them were exposed to a potential drug interaction between purchased OTC drug for self-medication and their POM. Furthermore, 116 (26 x 7%) regular customers were exposed to potential drug interactions within their prescribed drugs and in 28 (6 x 5%) multiple (>or=2) potential drug interactions were found. Two hundred and three (46 x 8%) regular customers were aware of potential drug interactions between their POM and OTC drugs. Ninety-six (47 x 3%) of them were informed by their prescribing physician and 52 (25 x 6%) by their community pharmacist. Awareness of potential drug interaction was higher in younger customers [odds ratio (OR) 0 x 95; 95% confidence intervals (CI) 0 x 93, 0 x 97, P<0 x 0001] and higher for drug interactions classified as 'severe' [OR 1 x 79; 95% CI 1 x 16, 2 x 77, P=0 x 009].
Efforts to increase awareness of potential drug interactions is needed. Although community pharmacies are adequately equipped with computerized drug interaction surveillance systems this is often not applied to self-medication. Vigilance for potential interactions of all drugs, including those sold over the counter, should be increased.
在社区药房中,处方药(POM)与用于自我药疗的非处方药(OTC)之间的潜在药物相互作用主要出现在两种情况下:(i)当一名路人顾客购买非处方药时,其处方药治疗情况未知;或(ii)当一名常客购买非处方药或处方药时,其处方药治疗情况通常已有记录。通过本研究,我们旨在评估路人顾客和常客中与选定的处方药和非处方药之间潜在药物相互作用的发生率,以及他们对这些潜在药物相互作用的认知情况。
通过观察顾客接触情况,并对购买选定非处方药的路人顾客进行访谈,以及对社区药房数据库中确定的接受选定处方药治疗的常客进行电话访谈,在瑞士巴塞尔地区的14家社区药房收集数据。选定的处方药和非处方药是那些可能导致不同严重程度的临床相关药物相互作用,但可通过不同干预措施(如调整剂量及其时间和/或监测治疗,以及通过选择替代治疗避免联合用药)进行管理的药物。
在观察的1183名路人顾客中,164名(14.4%)至少购买了一种选定的非处方药。其中102名(62.2%)接受了访谈。43名(42.2%)提到正在服用处方药,其中3名面临中度严重程度的潜在药物相互作用。从社区药房数据库中选出的592名常客中,434名(73.3%)接受了访谈。其中69名(15.9%)面临购买用于自我药疗的非处方药与其处方药之间的潜在药物相互作用。此外,116名(26.7%)常客面临其处方药之间的潜在药物相互作用,并且发现28名(6.5%)存在多种(≥2种)潜在药物相互作用。203名(46.8%)常客知晓其处方药与非处方药之间的潜在药物相互作用。其中96名(47.3%)由其开处方的医生告知,52名(25.6%)由其社区药剂师告知。年轻顾客对潜在药物相互作用的认知更高[优势比(OR)0.95;95%置信区间(CI)0.93,0.97,P<0.0001],对于分类为“严重”的药物相互作用认知也更高[OR 1.79;95%CI 1.16,2.77,P = 0.009]。
需要努力提高对潜在药物相互作用的认知。尽管社区药房配备了完善的计算机化药物相互作用监测系统,但这一系统往往未应用于自我药疗。应提高对所有药物潜在相互作用的警惕,包括那些非处方药。